Services & Pricing


Service Description


Non-KU Academic

                                                             Non-Academic Investigators                          

Probe synthesis

Organic synthesis or peptide synthesis, purification, and shipment of molecular probes to investigators

$1,754.00 (e.g. for 100 mg of a typical small molecule probe prepared in three steps)

Peptides of up to 20 amino acids can generally be prepared on a 100 mg scale in > 90% purity for $25/residue plus the cost of materials

Price for KU investigators x 1.6 Price for KU investigators x 2.0

Phenotypic screening of zebrafish embryos by microscopy in 96-well format (four embryos per well)

$10 per well

Price for KU investigators x 1.6

Price for KU investigators x 2.0

Assay development and other imaging services

A wide variety of microscopy-based assays can be developed and conducted using fluorescence dissecting microscopy or confocal fluorescence microscopy to investigate molecular probes in mammalian cells or zebrafish models

Please request a quote

Microscopes available:

Zeiss Axiozoom V16 fluorescence dissecting microscope: $20 per hour

Leica SPE Confocal Laser Scanning Microscope: $20 per hour

Price for KU investigators x 1.6 Price for KU investigators x 2.0


The table above provides a general guide to services offered by the KU-MPC. For synthetic projects, because molecular probes vary widely in complexity, the prices listed above reflect the cost of a typical synthesis of 100 mg of a small molecule probe from inexpensive starting materials requiring approximately three synthetic steps. Prices are subject to change based on specific requirements. To obtain a quote for a project, please contact Dr. Chamani Perera or Dr. Blake Peterson for free consultation.

CMADP Events
Special seminar by Dr. Kevin W. Plaxco
Professor of Chemistry & Biochemistry
UC Santa Barbara

Wednesday, April 19, 2017 at 4:00pm
School of Pharmacy, Room 3020

"Counting molecules, dodging blood cells: real-time molecular measurements directly in the living body"
The development of technology capable of continuously tracking the levels of drugs, metabolites, and biomarkers in situ in the body would revolutionize our understanding of health and our ability to detect and treat disease. It would, for example, provide clinicians with a real-time window into organ function and would enable therapies guided by patient-specific, real-time pharmacokinetics, opening a new dimension in personalized medicine. In response my group has pioneered the development of a “biology-inspired” electrochemical approach to monitoring specific molecules that supports real-time measurements of arbitrary molecular targets (irrespective of their chemical reactivity) directly in awake, fully ambulatory subjects.